0.25 USD
↘ 0.01 (3.58%)AT CLOSE (11:59 AM EDT)
AEON Biopharma, Inc.
AEONAMEX • USD
0.25
↘ 0.00 (0.68%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.25
↘ 0.00 (0.68%)
Market: CLOSED
AEON is currently priced at $0.25. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (358.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jul 24, 2026.
Open?$0.26
High?$0.26
Low?$0.24
Prev. Close?$0.26
Volume?285.0K
Avg. Volume?2.3M
VWAP?$0.25
Rel. Volume?0.12x
Bid / Ask
Bid?$0.24 × 600
Ask?$0.28 × 100
Spread?$0.03
Midpoint?$0.26
Valuation & Ratios
Market Cap?11.0M
Shares Out?26.3M
Float?9.4M
Float %?35.9%
P/E Ratio?N/A
P/B Ratio?-0.66
EPS?-$1.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Employees
8
Market Cap
11.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-24
Address
5 PARK PLAZA
IRVINE, CA 92614
Phone: (949) 354-6499
IRVINE, CA 92614
Phone: (949) 354-6499
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-85.02Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?11.80%High
Short Interest?1.1M
Days to Cover?1.0
Free Float9.4M
Avg Daily Volume6.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?0.99Weak
Quick Ratio?0.99Weak
Cash Ratio?0.94Adequate
Debt/Equity?-0.16Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.66CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?358.8%STRONG▾
Peers50
S&P97
ROA?-696.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12035000
Enterprise Value?$7.5M
Fundamentals ratios updated end of day